Vivos Therapeutics, Inc. - Common Stock (VVOS)

Discover the stocks with unexpected trading volume in today's session on the US markets.

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Vivos Therapeutics shares are trading lower by 25% Thursday morning. The company announced a $4.3 million registered offering.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.

NVDA, TMUS, VVOS, SOFI, TSLA are the top trending stocks on Wednesday.

The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive sleep apnea and snoring in children aged 6-17.

VVOS stock results show that Vivos Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

We are covering the biggest pre-market stock movers for Wednesday with all of the latest happenings worth watching this morning!

Vivos Therapeutics just reported results for the first quarter of 2024.

Vivos Therapeutics shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million shares of common stock by selling shareholders. Vivos said that if the warrants held by the selling stockholder are exercised in full for cash, the company would receive approximately $8.4 million.

Laser Photonics stock is rising higher on Tuesday as LASE investors celebrate a new unit order from L3Harris Technologies.

Vivos Therapeutics stock is up on Tuesday as VVOS investors react to the company securing full Medicare reimbursement for its OSA device.